Lifeboat Foundation

Forget all the nanotechnology devoted to fighting cancer, and just consider that nanoparticles have invaded makeup, anti-odor socks, sunscreen, plastic beer bottles and home pregnancy tests. Now scientists have developed a way to assess the health and environmental impact of such nanoparticles: a tiny microresonator that can detect and measure individual particles smaller than a single virus.

The microresonator is a lab-on-a-chip that harnesses the “whispering gallery” concept that’s displayed by buildings such as St. Paul’s Cathedral in London. The cathedral’s domed gallery can carry whispers easily across to the other side, but normal-volume voices end up garbled after bouncing around the dome multiple times.

Similarly, microresonators can bounce laser light many times around a circular “waveguide,” such as a glass ring. A laser frequency must perfectly fit the circumference of a ring to achieve this whispering-gallery mode.

A new treatment successfully restored the ability to walk in a group of lab mice with spinal cord injuries! And it took only four weeks.

Researchers in Japan say they have started a clinical trial of ovarian cancer treatment involving immune cells created from induced pluripotent stem cells, or iPS cells.

The team of researchers from the National Cancer Center Hospital East and Kyoto University’s Center for iPS Cell Research and Application made the announcement in an online news conference on Thursday.

The iPS cells used in the treatment are capable of developing into any kind of cell. A gene that reacts strongly to a protein unique to a certain type of ovarian cancer is inserted into iPS cells to create natural killer cells. These NK cells will then be injected into the ovaries of patients with this type of ovarian cancer.

Elon Musk’s revolutionary company Neuralink plans to insert Computer Chips into peoples brains but what if there’s a safer and even more performant way of merging humans and machines in the future?
Enter DARPAs plan to help the emergence of non-invasive brain computer interfaces which led to the organization Battelle to create a kind of Neural Dust to interface with our brains that might be the first step to having Nanobots inside of the human body in the future.

How will Neuralink deal with that potential rival with this cutting edge technology? Its possibilities in Fulldive Virtual Reality Games, Medical Applications, merging humans with artificial intelligence and its potential to scale all around the world are enormous.

Continue reading “Is Elon Musk’s NEURALINK ALREADY OBSOLETE? | Future of Brain Computer Interfaces” »

Innovation At The Intersection Of Cancer & Aging, Via Digital Health & Behavioral Sciences — Dr. Corinne Leach, Ph.D. American Cancer Society

Dr. Corinne Leach, PhD, MPH, MS, is a gerontologist, digital health strategist, and behavioral scientist, who serves as the Senior Principal Scientist, Behavioral Research, at the American Cancer Society (https://www.cancer.org/).

Continue reading “Dr Corinne Leach, Ph.D. — Gerontology, Digital Health, Behavioral Science — American Cancer Society” »

Meet Artemis Security, the company breaking ground in the realm of security for Israelis, from homes to hospitals.

𝐏𝐬𝐢𝐥𝐨𝐜𝐲𝐛𝐢𝐧 𝐅𝐨𝐮𝐧𝐝 𝐓𝐨 𝐑𝐚𝐩𝐢𝐝𝐥𝐲 𝐈𝐦𝐩𝐫𝐨𝐯𝐞 𝙍𝙖𝙥𝙞𝙙𝙡𝙮 𝙄𝙢𝙥𝙧𝙤𝙫𝙚 𝘿𝙚𝙥𝙧𝙚𝙨𝙨𝙞𝙫𝙚 𝙎𝙮𝙢𝙥𝙩𝙤𝙢𝙨 𝙄𝙣 𝙋𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝘿𝙪𝙧𝙞𝙣𝙜 ‘𝙂𝙧𝙤𝙪𝙣𝙙𝙗𝙧𝙚𝙖𝙠𝙞𝙣𝙜’ 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙏𝙧𝙞𝙖𝙡

𝙄𝙩 𝙩𝙪𝙧𝙣𝙨 𝙤𝙪𝙩 𝙩𝙝𝙖𝙩 𝙜𝙞𝙫𝙞𝙣𝙜 𝙥𝙨𝙞𝙡𝙤𝙘𝙮𝙗𝙞𝙣, … See more.

Compass Pathways, a U.K. based clinical stage company that is developing a patented form of psilocybin to be used in conjunction with therapy, reported promising results from its much-anticipated phase two b clinical trial this week. The study found that patients who took a single psychedelic dose of psilocybin, 25 milligrams, in conjunction with therapy reported almost immediate and significant reduction in depressive symptoms that lasted weeks compared with patients who were given a 1 milligram dose, which is so low it’s essentially a placebo.

Continue reading “Psilocybin Found To Rapidly Improve Depressive Symptoms In Patients During ‘Groundbreaking’ Clinical Trial” »

US scientists have developed a new form of drug that promotes the regeneration of cells and reversed paralysis in mice with spinal injuries, allowing them to walk again within four weeks of treatment.

The research was published in the journal Science on Thursday, and the team of Northwestern University scientists behind it hope to approach the Food and Drug Administration (FDA) as early as next year to propose human trials.

Continue reading “In Astonishing Feat, a New Drug Reversed Paralysis in Mice With Spinal Cord Injury” »

The degradation and regeneration of myelin sheaths characterize neurological disorders such as multiple sclerosis. Cholesterol is an indispensable component of myelin sheaths. The cholesterol for the regenerated myelin sheaths must therefore either be recycled from damaged myelin or produced again locally.

In a recent study, scientists at the Max Planck Institute for Experimental Medicine in Göttingen, led by Gesine Saher, found that in the case of chronic damage, unlike in acute damage, hardly any cholesterol is recycled. Instead, the new production of cholesterol determines the efficiency of the repair. Unexpectedly, not only the myelin-forming cells themselves but also nerve cells make an important contribution to regeneration.

Cholesterol synthesis in nerve cells ensures the replenishment of newly myelin-forming cells. This could impact the therapeutic success for myelin disorders such as multiple sclerosis.